{{Rsnum
|rsid=13432159
|Chromosome=2
|position=67746755
|Orientation=plus
|GMAF=0.07438
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 1.8 | 12.4 | 85.8
| HCB | 0.0 | 10.9 | 89.1
| JPT | 0.0 | 1.8 | 98.2
| YRI | 2.7 | 23.1 | 74.1
| ASW | 1.8 | 19.3 | 78.9
| CHB | 0.0 | 10.9 | 89.1
| CHD | 0.0 | 10.1 | 89.9
| GIH | 0.0 | 9.9 | 90.1
| LWK | 0.0 | 24.5 | 75.5
| MEX | 0.0 | 5.2 | 94.8
| MKK | 0.6 | 14.7 | 84.6
| TSI | 1.0 | 15.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22041458
|Trait=None
|Title=Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.
|RiskAllele=G
|Pval=9E-8
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}